Fig. 1From: Efficacy of immune checkpoint inhibitors in non-small cell lung cancer with NTRK family mutationsThe characteristics of NTRK mutation in patients with non-small cell lung cancer (NSCLC). A: The mutation spectrum of NTRK mutation in NSCLC patients. B: The association between NTRK mutation and smoking history, sex. C: Survival analysis in NTRK altered and unaltered patients with NSCLC. D-F: Survival analysis in NTRK1/2/3 MT and WT patients with NSCLC.Back to article page